KLCMU
XENT

Kite Lake Capital Management (UK)’s Intersect ENT, Inc XENT Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,320,000
Closed -$36M – 10
2021
Q4 		$36M Buy
+1,320,000
New +$35.8M 8.47% 6

Other funds holding XENT

VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kite Lake Capital Management (UK)'s XENT Position: Q1 2022 in Review

Kite Lake Capital Management (UK) sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 1,320,000 shares — an estimated $36M sold.

Kite Lake Capital Management (UK) first reported a position in XENT in Q4 2021 and held it in 1 quarter. The position peaked at $36M in Q4 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Kite Lake Capital Management (UK) reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
  • Kite Lake Capital Management (UK) sold 1,320,000 Intersect ENT, Inc shares in Q1 2022, an estimated $36M.
  • Kite Lake Capital Management (UK) first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 1 quarter.
  • Kite Lake Capital Management (UK)'s Intersect ENT, Inc position peaked at $36M in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q1 2022, filed 16 May 2022.